Indegene Acquires BioPharm: Expands Marketing Services

By By Rediff Money Desk, New Delhi
Oct 01, 2025 19:32
Indegene acquires BioPharm, a US-based marketing services agency, for up to $106M. Expands commercialization capabilities for life sciences.
New Delhi, Oct 1 (PTI) Healthcare tech firm Indegene on Wednesday said it has acquired BioPharm, a Pennsylvania-based specialised marketing services agency and part of Omnicom Health Group.

Total purchase consideration amount is up to USD 106 million, subject to cash/net working capital adjustments, the company said in a regulatory filing.

"This acquisition reinforces our position as the preferred tech-native, commercialisation partner for the life sciences industry, helping clients unlock greater strategic value from their marketing and AdTech investments," Manish Gupta, Chairman and CEO of Indegene, said.

Founded in 2005, BioPharm's clients include 17 of the world's top 25 biopharma organisations.
Source: PTI
Read More On:
indegenebiopharmacquisitionmarketing serviceslife sciences
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

You May Like To Read

MORE NEWS

India Logistics Cost Down to 9%: Gadkari

Nitin Gadkari says India has met its target to reduce logistics cost to 9% of GDP due...

Coal Mining: Panel Urges Faster Green Clearances

Parliamentary panel urges faster environmental & forest clearances for coal mining...

DCM Shriram & Bayer Crop Science Collaboration

DCM Shriram and Bayer Crop Science partner to explore agricultural opportunities in...

Silver Price Soars to Rs 1.92 Lakh/kg on Global...

Silver prices surge Rs 11,500 to Rs 1.92 lakh/kg in Delhi amid strong global cues. Gold...

Urea Fixed Costs to Rise for Manufacturers

Govt plans to raise fixed costs for urea makers by year-end. Decision expected soon,...

Bullion Rates Today: Gold & Silver Prices

Check today''s closing bullion rates in Bengaluru. Gold (22K & 24K) prices per gram and...

Bank of India Raises Rs 2,500 Cr via Tier II Bonds

Bank of India (BoI) raised Rs 2,500 crore through Basel III-compliant Tier II bonds at...

Cipla Launches Obesity & Diabetes Drug Yurpeak

Cipla launches Yurpeak (tirzepatide), a weekly injectable for obesity and type-2...

Sebi Eases KYC for NRIs, Removes Physical Presence

Sebi relaxes re-KYC for NRIs, removing physical presence requirement for digital...

OPTCL & NABARD Pact: Power Boost in Odisha

OPTCL and NABARD sign MoU for power infrastructure development in Odisha. NABARD...

Read More »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com